Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 85 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 7645775

    Triazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted

  2. US 7642275

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  3. US 7642253

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  4. US 7642280

    Inhibitors of acyl glucosaminyl inositol amidase and methods of use

    The Regents of the University of California · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  5. US 7638638

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  6. US 7638543

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    The Regents of the University of California · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  7. US 7635683

    Quinoxalinyl tripeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 22, 2009 · Expires Dec 17, 2029

    granted

  8. US 7625913

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  9. US 7622463

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  10. US 7615573

    Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted

  11. US 7612065

    Inhibitors of c-JUN N-terminal kinases (JNK)

    Vertex Pharmaceuticals Incorporated · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

  12. US 7612091

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

  13. US 7608632

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted

  14. US 7605126

    Acylaminoheteroaryl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted

  15. US 7601713

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  16. US 7601709

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  17. US 7601718

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  18. US 7598277

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  19. US 7598245

    Aminotriazole compounds useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  20. US 7595326

    Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs

    Champions Biotechnology, Inc · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted

  21. US 7592368

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted

  22. US 7592343

    Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted

  23. US 7592340

    Quinoxalines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted

  24. US 7589220

    Inhibitors of the anandamide transporter

    UNIVERSITY OF CONNECTICUT · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.